Redemplo Injection, Solution
Product Images NDC 84141-025
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Redemplo (NDC 84141-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Arrowhead Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Plozasiran 02)
Figure 2 (Plozasiran 03)
Median Absolute Values in Triglycerides (mg/dL) were measured for subjects in a study involving Placebo (pooled) and Plozasiran 25mg treatments. The number of subjects at the visit varied across different measurements. The data presented also includes a syringe mark, which indicates the dosing schedule in Trial 1.*
Figure (Plozasiran 04)
Figure (Plozasiran 05)
Figure A (Plozasiran 06)
Figure B (Plozasiran 07)
Figure C (Plozasiran 08)
Figure D (Plozasiran 09)
Figure E (Plozasiran 10)
Figure F (Plozasiran 11)
Figure G (Plozasiran 12)
Figure H (Plozasiran 13)
Figure I (Plozasiran 14)
Figure J (Plozasiran 15)
Figure K (Plozasiran 16)
Figure L (Plozasiran 17)
Figure M (Plozasiran 18)
Figure N (Plozasiran 19)
Carton Label (25mg/0.5mL)
Container Label (25mg/0.5mL)
This text provides information about Redemplo® (plozasiran) injection with a concentration of 25 mg/0.5 mL for subcutaneous use. It includes the NDC number, dosage details, prescription information, single-dose indication, manufacturer details, lot number, expiration date, and a unique identifier code.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.